Breast implant-associated lymphoma has recently gained wide recognition. Anaplastic large cell lymphoma (ALCL) is the most frequently diagnosed subtype in this setting but the spectrum is broadening. A 66-year-old woman developed swelling and itch around her saline implant 6 years after its insertion. Imaging revealed a fluid collection surrounding the implant with an adjacent mass. Microscopy showed sclerotic tissue punctuated by discrete cellular nodules comprising small lymphocytes, eosinophils and interspersed large atypical Hodgkin Reed-Sternberg (HRS)-like cells. The HRS-like cells stained positively for CD30 and CD15 by immunohistochemistry. Small T-lymphocytes formed rosettes around HRS-like cells. Appearances were consistent with classical Hodgkin lymphoma (HL). Multiplex polymerase chain reaction demonstrated no clonal rearrangements of immunoglobulin or T-cell receptor genes, however, a t(14;18)(q32;q21)BCL2-JH translocation involving the major breakpoint region of the bcl2 gene was present. Staging positron emission tomography-computed tomography scan revealed FDG-avid masses in the right axilla and pelvis. Subsequent pathological examination identified low-grade follicular lymphoma (FL) with a t(14;18) translocation at these sites. To our knowledge, this is the first case of HL arising adjacent to a breast implant. An awareness of this diagnosis is important as classical HL, with its prominent mixed inflammatory background, may be overlooked as a reactive process when histologically assessing capsulectomy specimens. It is also important in the differential diagnosis for implant-associated ALCL as both contain large atypical CD30-positive cells highlighting the need for full immunohistochemical and molecular workup in such cases. This case also adds to the large body of literature regarding the association between HL and FL.

Download full-text PDF

Source
http://dx.doi.org/10.1177/1066896916632587DOI Listing

Publication Analysis

Top Keywords

hrs-like cells
12
classical hodgkin
8
hodgkin lymphoma
8
arising adjacent
8
adjacent breast
8
breast implant
8
large atypical
8
lymphoma
5
lymphoma arising
4
implant
4

Similar Publications

Lymphomas of T-follicular helper origin (T-follicular helper-cell lymphoma [TFHL]) are often accompanied by an expansion of B-immunoblasts, occasionally with Hodgkin/Reed-Sternberg-like (HRS-like) cells, making the differential diagnosis with classic Hodgkin lymphoma (CHL) difficult. We compared the morphologic, immunophenotypic, and molecular features of 15 TFHL and 12 CHL samples and discussed 4 challenging cases of uncertain diagnosis. Compared with CHL, TFHL disclosed more frequent sparing of subcortical sinuses, high-endothelium venule proliferation, dendritic cell meshwork expansion, T-cell atypia, and aberrant T-cell immunophenotype.

View Article and Find Full Text PDF
Article Synopsis
  • A study evaluated a triplet therapy of chidamide, decitabine, and camrelizumab (CDP) in patients with relapsed/refractory classic Hodgkin lymphoma (cHL) who previously underwent DNA methyltransferase inhibitor decitabine plus anti-PD-1 therapy.
  • CDP treatment was well-received, with a 94% objective response rate and 50% of patients achieving complete response, even in those who initially resisted DP therapy.
  • Research using single-cell RNA sequencing revealed interactions between malignant cells and immunosuppressive T cells, indicating that CDP treatment enhances anti-tumor responses while reducing immunosuppressive effects, offering a promising approach to overcoming immunotherapy resistance.
View Article and Find Full Text PDF

Genetic abnormalities assist in pathological diagnosis and EBV-positive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients.

Chin J Cancer Res

October 2023

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing 100142, China.

Article Synopsis
  • This study investigates how genetic abnormalities can aid in diagnosing angioimmunoblastic T-cell lymphoma (AITL) and identifying reliable prognostic factors.
  • Researchers analyzed 53 AITL cases, focusing on morphological features, immunophenotypes, and the presence of certain cells, while also conducting targeted exome sequencing for mutations.
  • The findings suggest that genetic mutation data can significantly improve diagnosis and indicate that high-density EBER presence is associated with poorer overall and progression-free survival rates.
View Article and Find Full Text PDF

[Progressively transformed germinal center-like follicular T-cell lymphoma:a clinicopathological analysis of 14 cases].

Zhonghua Bing Li Xue Za Zhi

November 2023

Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.

To investigate the clinicopathologic features of progressively transformed germinal center-like follicular T-cell lymphoma (PTGC-like FTCL). The clinicopathologic data of 14 PTGC-like FTCL cases that were diagnosed at the Beijing Friendship Hospital Affiliated to the Capital Medical University from January 2017 to January 2022 were retrospectively collected. Clinicopathological features, immunophenotype, and Epstein-Barr virus (EBV) infection status were analyzed in these cases.

View Article and Find Full Text PDF

[Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma].

Beijing Da Xue Xue Bao Yi Xue Ban

June 2023

Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China.

Objective: To analyze the clinicopathological features, molecular changes and prognostic factors in angioimmunoblastic T-cell lymphoma (AITL).

Methods: Sixty-one cases AITL diagnosed by Department of Pathology of Peking University Cancer Hospital were collected with their clinical data. Morphologically, they were classified as typeⅠ[lymphoid tissue reactive hyperplasia (LRH) like]; typeⅡ[marginal zone lymphoma(MZL)like] and type Ⅲ [peripheral T-cell lymphoma, not specified (PTCL-NOS) like].

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!